Newpath Partners kicks off $350M fund with a wunderkind holding the bag and an all-star scientific team waiting in the wings

The world of biotech isn’t short on big personalities, but it’s not exactly common to see young professionals earning the broad respect of seasoned academics. Yet, Tom Cahill and his team at Newpath have snagged the support of some of biotech’s biggest names in just a few short years in...

Click to view original post